Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases

US Patent 9125913 · Granted Sep 8, 2015

Estimated economic value: $486,264,000

Assignee

Inventors

View full patent text on Google Patents →